PL2744802T3 - Związki do wiązania do glikoproteiny IIB/IIIA specyficznej wobec płytek i ich zastosowanie do obrazowania zakrzepów - Google Patents
Związki do wiązania do glikoproteiny IIB/IIIA specyficznej wobec płytek i ich zastosowanie do obrazowania zakrzepówInfo
- Publication number
- PL2744802T3 PL2744802T3 PL12750331T PL12750331T PL2744802T3 PL 2744802 T3 PL2744802 T3 PL 2744802T3 PL 12750331 T PL12750331 T PL 12750331T PL 12750331 T PL12750331 T PL 12750331T PL 2744802 T3 PL2744802 T3 PL 2744802T3
- Authority
- PL
- Poland
- Prior art keywords
- thrombi
- iiia
- imaging
- binding
- compounds
- Prior art date
Links
- 102000003886 Glycoproteins Human genes 0.000 title 1
- 108090000288 Glycoproteins Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000003384 imaging method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11075195 | 2011-08-17 | ||
| EP12750331.6A EP2744802B1 (en) | 2011-08-17 | 2012-08-17 | Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2744802T3 true PL2744802T3 (pl) | 2017-07-31 |
Family
ID=46724333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12750331T PL2744802T3 (pl) | 2011-08-17 | 2012-08-17 | Związki do wiązania do glikoproteiny IIB/IIIA specyficznej wobec płytek i ich zastosowanie do obrazowania zakrzepów |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9345793B2 (pl) |
| EP (1) | EP2744802B1 (pl) |
| JP (2) | JP6243335B2 (pl) |
| KR (1) | KR101948362B1 (pl) |
| CN (1) | CN103906743B (pl) |
| AU (1) | AU2012297137B2 (pl) |
| BR (1) | BR112014003366B1 (pl) |
| CA (1) | CA2845477C (pl) |
| DK (1) | DK2744802T3 (pl) |
| ES (1) | ES2621379T3 (pl) |
| HR (1) | HRP20170464T1 (pl) |
| IL (1) | IL230854A (pl) |
| MX (1) | MX352546B (pl) |
| MY (1) | MY174617A (pl) |
| NZ (1) | NZ620635A (pl) |
| PL (1) | PL2744802T3 (pl) |
| PT (1) | PT2744802T (pl) |
| RU (1) | RU2597425C2 (pl) |
| SG (1) | SG2014011225A (pl) |
| SI (1) | SI2744802T1 (pl) |
| WO (1) | WO2013023795A1 (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3091326B2 (ja) | 1992-08-25 | 2000-09-25 | 松下電工株式会社 | 成膜方法 |
| PL2744802T3 (pl) * | 2011-08-17 | 2017-07-31 | Piramal Imaging Sa | Związki do wiązania do glikoproteiny IIB/IIIA specyficznej wobec płytek i ich zastosowanie do obrazowania zakrzepów |
| KR101493571B1 (ko) * | 2012-12-24 | 2015-02-13 | (주)엘지하우시스 | 저방사 투명 적층체 및 이를 포함하는 건축 자재 |
| JP6099045B2 (ja) * | 2013-04-30 | 2017-03-22 | 国立大学法人京都大学 | トリアゾロピリミジン誘導体化合物 |
| JP5847140B2 (ja) * | 2013-08-29 | 2016-01-20 | 国立大学法人東北大学 | 慢性血栓塞栓性肺高血圧症の検査方法 |
| WO2015121163A1 (en) * | 2014-02-11 | 2015-08-20 | Bayer Pharma Aktiengesellschaft | Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia |
| JP2015193545A (ja) * | 2014-03-31 | 2015-11-05 | 国立大学法人京都大学 | ２−（３−ピリジニル）−１ｈ−ベンズイミダゾール誘導体化合物、これを含む放射性医薬 |
| CN105699563A (zh) * | 2016-04-25 | 2016-06-22 | 广西壮族自治区梧州食品药品检验所 | 双波长高效液相色谱检测血栓通的方法 |
| US10610104B2 (en) | 2016-12-07 | 2020-04-07 | Progenity, Inc. | Gastrointestinal tract detection methods, devices and systems |
| JP7150723B2 (ja) | 2016-12-14 | 2022-10-11 | ビオラ・セラピューティクス・インコーポレイテッド | 消化管疾病のインテグリン阻害薬による治療 |
| WO2019246455A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
| WO2020106757A1 (en) | 2018-11-19 | 2020-05-28 | Progenity, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
| CN115666704B (zh) | 2019-12-13 | 2025-09-26 | 比特比德科有限责任公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
| KR102548998B1 (ko) * | 2020-03-31 | 2023-06-29 | 재단법인 아산사회복지재단 | 혈전영상을 위한 방사성의약품 및 조성물 |
| US20240208968A1 (en) * | 2021-03-10 | 2024-06-27 | Dice Molecules Sv, Inc. | Alpha v beta 6 and alpha v beta 1 integrin inhibitors and uses thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ239846A (en) | 1990-09-27 | 1994-11-25 | Merck & Co Inc | Sulphonamide derivatives and pharmaceutical compositions thereof |
| US5830856A (en) | 1991-02-08 | 1998-11-03 | Diatide, Inc. | Radiolabeled compounds for thrombus imaging |
| US5645815A (en) | 1991-02-08 | 1997-07-08 | Diatide, Inc. | Radiolabled compounds for thrombus imaging |
| US5508020A (en) | 1992-06-05 | 1996-04-16 | Diatech, Inc. | Technetium-99M labeled peptides for imaging |
| US6380215B1 (en) | 1993-09-22 | 2002-04-30 | Fujisawa Pharmaceutical Co., Ltd | Beta-alanine derivative and a process for the preparation thereof |
| EP0869944A1 (en) | 1995-03-17 | 1998-10-14 | Fujisawa Pharmaceutical Co., Ltd. | N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS |
| DE19540700A1 (de) | 1995-11-02 | 1997-05-07 | Daniels & Korff Gmbh | Oberhemd mit Kragen |
| EP0888302A1 (en) | 1996-03-13 | 1999-01-07 | Fujisawa Pharmaceutical Co., Ltd. | N- (r)-1- 3-(4-piperidyl)propionyl-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist |
| GEP20002187B (en) * | 1996-05-01 | 2000-07-25 | Ortho Pharma Corp | Carboxamide Derivatives of Pyrrolidine, Piperidine and Hexahydroazepine, Composition for the Treatment of Thrombosis Disorders Induced by Thrombocytes, Intermediate Compounds and Method for Their Preparation |
| US6066651A (en) | 1997-10-29 | 2000-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
| US6028056A (en) | 1998-02-06 | 2000-02-22 | Diatide, Inc. | Pharmaceutical compositions for imaging and treating thrombi |
| ATE242235T1 (de) | 1999-03-22 | 2003-06-15 | Ortho Mcneil Pharm Inc | Verfahren zur herstellung von (s-(r*,s*))-g(b)- ((1-(1-oxo-3-(4-piperidinyl)propyl)-3- piperidinyl)carbonyl) amino)-3- pyridinpropansäurederivate |
| EP2404899A1 (en) * | 2004-02-25 | 2012-01-11 | Astellas Pharma Inc. | Contrast medium for thrombus detection |
| WO2010000409A2 (en) * | 2008-07-03 | 2010-01-07 | Bayer Schering Pharma Aktiengesellschaft | Compounds and processes for production of radiopharmaceuticals |
| WO2010038081A2 (en) | 2008-10-03 | 2010-04-08 | Astrazeneca Ab | Heterocyclic derivatives and methods of use thereof |
| PL2744802T3 (pl) * | 2011-08-17 | 2017-07-31 | Piramal Imaging Sa | Związki do wiązania do glikoproteiny IIB/IIIA specyficznej wobec płytek i ich zastosowanie do obrazowania zakrzepów |
-
2012
- 2012-08-17 PL PL12750331T patent/PL2744802T3/pl unknown
- 2012-08-17 SG SG2014011225A patent/SG2014011225A/en unknown
- 2012-08-17 MY MYPI2014000391A patent/MY174617A/en unknown
- 2012-08-17 US US14/239,065 patent/US9345793B2/en active Active
- 2012-08-17 AU AU2012297137A patent/AU2012297137B2/en active Active
- 2012-08-17 NZ NZ620635A patent/NZ620635A/en not_active IP Right Cessation
- 2012-08-17 EP EP12750331.6A patent/EP2744802B1/en active Active
- 2012-08-17 PT PT127503316T patent/PT2744802T/pt unknown
- 2012-08-17 CN CN201280050196.4A patent/CN103906743B/zh active Active
- 2012-08-17 DK DK12750331.6T patent/DK2744802T3/en active
- 2012-08-17 SI SI201230874A patent/SI2744802T1/sl unknown
- 2012-08-17 JP JP2014525352A patent/JP6243335B2/ja active Active
- 2012-08-17 KR KR1020147006644A patent/KR101948362B1/ko active Active
- 2012-08-17 BR BR112014003366-8A patent/BR112014003366B1/pt active IP Right Grant
- 2012-08-17 RU RU2014109853/04A patent/RU2597425C2/ru active
- 2012-08-17 WO PCT/EP2012/003583 patent/WO2013023795A1/en not_active Ceased
- 2012-08-17 MX MX2014001784A patent/MX352546B/es active IP Right Grant
- 2012-08-17 CA CA2845477A patent/CA2845477C/en active Active
- 2012-08-17 ES ES12750331.6T patent/ES2621379T3/es active Active
- 2012-08-17 HR HRP20170464TT patent/HRP20170464T1/hr unknown
-
2014
- 2014-02-06 IL IL230854A patent/IL230854A/en active IP Right Grant
-
2016
- 2016-01-21 US US15/003,368 patent/US9744252B2/en active Active
- 2016-11-21 JP JP2016225839A patent/JP2017075159A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG2014011225A (en) | Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi | |
| AP2013007094A0 (en) | Composite absorbent material | |
| IL225781A0 (en) | Composite material containing gradient-nano-particles/allotrope of carbon/polymer | |
| GB201122296D0 (en) | Composite materials | |
| SG10201605328WA (en) | Nanofiber containing composite structures | |
| IL236525A0 (en) | Antibodies against conserved targets | |
| SG10201707211WA (en) | Nanofiber containing composite structures | |
| IL230501A0 (en) | Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and their use as a5c receptor modulators | |
| PH12012502303A1 (en) | Natural nonwoven materials | |
| PL2743692T3 (pl) | Mikrochipowe urządzenie do badania złożonych funkcji płytek krwi | |
| GB201013524D0 (en) | Improved composite materials | |
| ZA201408564B (en) | Zeolitic materials and methods for their preparation using alkenyltrialkylammonium compounds | |
| GB201111630D0 (en) | Novel compounds and their use | |
| PT2855496T (pt) | Processos de síntese e de purificação para compostos de fosfaplatina e aplicações dos mesmos | |
| GB201218352D0 (en) | Compounds and their synthesis | |
| DK2390092T3 (da) | Åndbar ikke-vævet komposit | |
| GB201507983D0 (en) | Improvements relating to railway structures | |
| IL225199A0 (en) | Assembly to preserve the function of blood platelets | |
| TWI560195B (en) | Novel synthesis of 5-deoxy-5'-fluorocytidine compounds | |
| GB201104130D0 (en) | Composite material | |
| GB201216335D0 (en) | He ain't heavy II | |
| PL393084A1 (pl) | Sposób wytwarzania kompozytowego sorbentu na bazie NiFN | |
| PL391428A1 (pl) | Kompozyt włókninowy | |
| GB201114073D0 (en) | Single container or multicontainer | |
| GB201102468D0 (en) | Biocompatible composite materials |